<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of&nbsp;Report (Date of earliest event reported): January&nbsp;24, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CNL&nbsp;HEALTHCARE PROPERTIES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Maryland</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>000-54685</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>27-2876363</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of&nbsp;Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>450 South Orange Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orlando, Florida 32801 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices; Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (407)&nbsp;650-1000 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule&nbsp;425 under the Securities Act
(17&nbsp;CFR&nbsp;230.425)</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17&nbsp;CFR&nbsp;240.14a-12)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act
(17&nbsp;CFR&nbsp;240.14d-2(b)) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule&nbsp;13e-4 (c)&nbsp;under the&nbsp;Exchange Act
(17&nbsp;CFR&nbsp;240.13e-4(c)) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulation FD Disclosure </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Correspondence with&nbsp;Financial Advisors and&nbsp;Broker Dealers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Filed as Exhibit 99.1 to&nbsp;this Current Report, and&nbsp;incorporated herein by&nbsp;reference, is the&nbsp;text of&nbsp;a correspondence
from CNL&nbsp;Healthcare Properties, Inc. (the&nbsp;&#147;Company&#148;)&nbsp;to&nbsp;financial advisors and&nbsp;broker dealers who&nbsp;participated in&nbsp;the&nbsp;Company&#146;s public offerings, notifying them that the&nbsp;Company
(i)&nbsp;plans to&nbsp;prepare an&nbsp;estimated net asset value (&#147;NAV&#148;) per share of the Company&#146;s common&nbsp;stock as of&nbsp;December&nbsp;31,&nbsp;2018 (the&nbsp;&#147;2018&nbsp;NAV&#148;), (ii)&nbsp;anticipates announcing
the&nbsp;2018&nbsp;NAV on&nbsp;or about March&nbsp;19, 2019, (iii)&nbsp;recently engaged Robert A. Stanger&nbsp;&amp; Co., Inc., an&nbsp;independent investment banking firm (&#147;Stanger&#148;), to&nbsp;assist the Company
with&nbsp;the&nbsp;preparation&nbsp;of&nbsp;the&nbsp;estimated 2018 NAV, and&nbsp;(iv)&nbsp;will hold a&nbsp;webinar on&nbsp;March 21,&nbsp;2019, at 1:30&nbsp;p.m., Eastern Time, to&nbsp;review the&nbsp;estimated 2018&nbsp;NAV. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to&nbsp;the&nbsp;rules and&nbsp;regulations of&nbsp;the&nbsp;Securities and&nbsp;Exchange Commission&nbsp;(the&nbsp;&#147;SEC&#148;),
the&nbsp;information&nbsp;contained in this Item&nbsp;7.01 disclosure, including Exhibit 99.1 and&nbsp;the&nbsp;information&nbsp;set forth therein, is&nbsp;deemed to&nbsp;have been furnished and shall not be deemed to&nbsp;be &#147;filed&#148; under
the&nbsp;Securities Exchange Act of&nbsp;1934. By&nbsp;furnishing the&nbsp;information&nbsp;contained in this Item&nbsp;7.01 disclosure, including Exhibit 99.1, the&nbsp;Company makes no&nbsp;admission&nbsp;as&nbsp;to&nbsp;the&nbsp;materiality
of&nbsp;such information. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Events </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Determination&nbsp;of&nbsp;Net Asset Value per Share as of&nbsp;December 31,&nbsp;2018 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In&nbsp;order to&nbsp;assist Financial Industry Regulatory Authority (&#147;FINRA&#148;)&nbsp;members and&nbsp;their associated persons who
participated in&nbsp;the&nbsp;Company&#146;s public offerings in&nbsp;meeting their customer account statement reporting obligations under National Association of Securities Dealers Conduct Rule&nbsp;2340, the&nbsp;Company prepares
and&nbsp;announces at least annually an estimated NAV per share of its common stock, the&nbsp;method by&nbsp;which such NAV was&nbsp;developed, and&nbsp;the&nbsp;date of the data used to develop the&nbsp;estimated NAV per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The&nbsp;Company now intends to&nbsp;establish and&nbsp;announce the&nbsp;estimated 2018&nbsp;NAV, on&nbsp;or about March&nbsp;19, 2019. To
assist the board of directors of the&nbsp;Company (the&nbsp;&#147;Board&#148;)&nbsp;and&nbsp;the&nbsp;Company&#146;s valuation&nbsp;committee, which is comprised solely of the Company&#146;s independent directors
(the&nbsp;&#147;Valuation&nbsp;Committee&#148;), with&nbsp;establishing the 2018 NAV as&nbsp;of&nbsp;December&nbsp;31, 2018 (the&nbsp;&#147;Valuation&nbsp;Date&#148;), the&nbsp;Company engaged Stanger to&nbsp;provide a&nbsp;net asset
value&nbsp;analysis&nbsp;of&nbsp;the&nbsp;Company. The engagement of Stanger was based on&nbsp;a&nbsp;number of&nbsp;factors including Stanger&#146;s experience in&nbsp;the&nbsp;valuation of assets similar to those owned by the Company. Upon the
receipt of&nbsp;a&nbsp;net asset value&nbsp;analysis of&nbsp;the&nbsp;Company from Stanger, which will contain, among other information, a range of per share net asset values for&nbsp;the&nbsp;Company&#146;s common&nbsp;stock as
of&nbsp;the&nbsp;Valuation&nbsp;Date (a &#147;Valuation Report&#148;), the Valuation Committee will consider the&nbsp;reasonableness of&nbsp;the&nbsp;range of&nbsp;per&nbsp;share values and&nbsp;make a&nbsp;recommendation to the Board, and the Board
will approve and&nbsp;adopt an&nbsp;estimated 2018 NAV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The&nbsp;Company will establish the&nbsp;2018&nbsp;NAV in&nbsp;accordance
with&nbsp;the&nbsp;Company&#146;s valuation policy and certain recommendations and methodologies of&nbsp;the&nbsp;Investment Program Association, a&nbsp;trade association&nbsp;for non-listed direct investment vehicles (&#147;IPA&#148;), as set forth
in IPA Practice Guideline 2013-01 &#147;Valuations of&nbsp;Publicly Registered Non-Listed REITs&#148; (&#147;IPA&nbsp;Practice Guideline 2013-01&#148;). In developing its valuation&nbsp;analysis of&nbsp;the&nbsp;Company, Stanger will also consider
IPA&nbsp;Practice Guideline 2013-01. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Robert A. Stanger&nbsp;&amp; Co., Inc. is a nationally recognized investment banking firm
specializing in providing strategic planning, investment banking, financial advisory, fairness opinion and valuation services to partnerships, real estate investment trusts and real estate advisory and management companies. Stanger possesses
substantial experience in the valuation&nbsp;of&nbsp;assets similar to&nbsp;those owned by&nbsp;the&nbsp;Company and&nbsp;regularly undertakes the&nbsp;valuation&nbsp;of&nbsp;securities. For the preparation of the Valuation Report, the&nbsp;Company
will pay Stanger a customary fee for services of this nature, no part of&nbsp;which was&nbsp;contingent relating to the provision of services or&nbsp;specific findings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is the Company&#146;s first engagement with Stanger as a&nbsp;third-party valuation&nbsp;advisor. The Company is not affiliated
with&nbsp;Stanger. While the&nbsp;Company and&nbsp;affiliates of&nbsp;the&nbsp;Company have engaged and may engage Stanger in the&nbsp;future for commercial real estate services of&nbsp;various kinds, the Company believes that there are
no&nbsp;material </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conflicts of&nbsp;interest with&nbsp;respect to&nbsp;the&nbsp;Company&#146;s engagement of&nbsp;Stanger. In the ordinary course of its business, Stanger, its affiliates, directors
and&nbsp;officers may structure and&nbsp;effect transactions for its own account or for the&nbsp;accounts of&nbsp;its customers in commercial real estate assets of&nbsp;the same kind and in the same markets as the Company&#146;s assets. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and&nbsp;Exhibits </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d696702dex991.htm">Text of&nbsp;correspondence to&nbsp;financial advisors and&nbsp;broker dealers. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: January&nbsp;24, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CNL HEALTHCARE PROPERTIES, INC.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Maryland corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Ixchell C. Duarte</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ixchell C. Duarte</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and
Treasurer</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
[{"type": "8-K", "sequence": "1", "filename": "d696702d8k.htm", "description": "8-K", "secsgml_size_bytes": 21289}]
{"company-data": {"conformed-name": "CNL Healthcare Properties, Inc.", "cik": "0001496454", "assigned-sic": "6798", "irs-number": "272876363", "state-of-incorporation": "MD", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54685", "film-number": "19539593"}, "business-address": {"street1": "450 SOUTH ORANGE AVENUE", "city": "ORLANDO", "state": "FL", "zip": "32801", "phone": "(407) 650-1000"}, "mail-address": {"street1": "450 SOUTH ORANGE AVENUE", "city": "ORLANDO", "state": "FL", "zip": "32801"}, "former-company": [{"former-conformed-name": "CNL Healthcare Trust, Inc.", "date-changed": "20120209"}, {"former-conformed-name": "CNL Properties Trust, Inc.", "date-changed": "20110301"}, {"former-conformed-name": "CNL Diversified Lifestyle Properties, Inc.", "date-changed": "20100713"}]}
8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 24, 2019
CNL HEALTHCARE PROPERTIES, INC.
(Exact Name of Registrant as Specified in its Charter)
Maryland
000-54685
27-2876363
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
450 South Orange Avenue
Orlando, Florida 32801
(Address of Principal Executive Offices; Zip Code)
Registrant's telephone number, including area code: (407) 650-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act
(17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Item 7.01
Regulation FD Disclosure
Correspondence with Financial Advisors and Broker Dealers
Filed as Exhibit 99.1 to this Current Report, and incorporated herein by reference, is the text of a correspondence
from CNL Healthcare Properties, Inc. (the "Company") to financial advisors and broker dealers who participated in the Company's public offerings, notifying them that the Company
(i) plans to prepare an estimated net asset value ("NAV") per share of the Company's common stock as of December 31, 2018 (the "2018 NAV"), (ii) anticipates announcing
the 2018 NAV on or about March 19, 2019, (iii) recently engaged Robert A. Stanger & Co., Inc., an independent investment banking firm ("Stanger"), to assist the Company
with the preparation of the estimated 2018 NAV, and (iv) will hold a webinar on March 21, 2019, at 1:30 p.m., Eastern Time, to review the estimated 2018 NAV.
Pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"),
the information contained in this Item 7.01 disclosure, including Exhibit 99.1 and the information set forth therein, is deemed to have been furnished and shall not be deemed to be "filed" under
the Securities Exchange Act of 1934. By furnishing the information contained in this Item 7.01 disclosure, including Exhibit 99.1, the Company makes no admission as to the materiality
of such information.
Item 8.01
Other Events
Determination of Net Asset Value per Share as of December 31, 2018
In order to assist Financial Industry Regulatory Authority ("FINRA") members and their associated persons who
participated in the Company's public offerings in meeting their customer account statement reporting obligations under National Association of Securities Dealers Conduct Rule 2340, the Company prepares
and announces at least annually an estimated NAV per share of its common stock, the method by which such NAV was developed, and the date of the data used to develop the estimated NAV per share.
The Company now intends to establish and announce the estimated 2018 NAV, on or about March 19, 2019. To
assist the board of directors of the Company (the "Board") and the Company's valuation committee, which is comprised solely of the Company's independent directors
(the "Valuation Committee"), with establishing the 2018 NAV as of December 31, 2018 (the "Valuation Date"), the Company engaged Stanger to provide a net asset
value analysis of the Company. The engagement of Stanger was based on a number of factors including Stanger's experience in the valuation of assets similar to those owned by the Company. Upon the
receipt of a net asset value analysis of the Company from Stanger, which will contain, among other information, a range of per share net asset values for the Company's common stock as
of the Valuation Date (a "Valuation Report"), the Valuation Committee will consider the reasonableness of the range of per share values and make a recommendation to the Board, and the Board
will approve and adopt an estimated 2018 NAV.
The Company will establish the 2018 NAV in accordance
with the Company's valuation policy and certain recommendations and methodologies of the Investment Program Association, a trade association for non-listed direct investment vehicles ("IPA"), as set forth
in IPA Practice Guideline 2013-01 "Valuations of Publicly Registered Non-Listed REITs" ("IPA Practice Guideline 2013-01"). In developing its valuation analysis of the Company, Stanger will also consider
IPA Practice Guideline 2013-01.
Robert A. Stanger & Co., Inc. is a nationally recognized investment banking firm
specializing in providing strategic planning, investment banking, financial advisory, fairness opinion and valuation services to partnerships, real estate investment trusts and real estate advisory and management companies. Stanger possesses
substantial experience in the valuation of assets similar to those owned by the Company and regularly undertakes the valuation of securities. For the preparation of the Valuation Report, the Company
will pay Stanger a customary fee for services of this nature, no part of which was contingent relating to the provision of services or specific findings.
This is the Company's first engagement with Stanger as a third-party valuation advisor. The Company is not affiliated
with Stanger. While the Company and affiliates of the Company have engaged and may engage Stanger in the future for commercial real estate services of various kinds, the Company believes that there are
no material
conflicts of interest with respect to the Company's engagement of Stanger. In the ordinary course of its business, Stanger, its affiliates, directors
and officers may structure and effect transactions for its own account or for the accounts of its customers in commercial real estate assets of the same kind and in the same markets as the Company's assets.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
99.1
Text of correspondence to financial advisors and broker dealers.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: January 24, 2019
CNL HEALTHCARE PROPERTIES, INC.
a Maryland corporation
By:
/s/ Ixchell C. Duarte
Ixchell C. Duarte
Chief Financial Officer and
Treasurer